✦ LIBER ✦

Brentuximab Vedotin (SGN-35), an antibody–drug conjugate for the treatment of CD30-positive malignancies

✍ Scribed by Gualberto, Antonio

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Handbook of Therapeutic Antibodies (Dübe

✍ Dübel, Stefan; Reichert, Janice M. 📂 Article 📅 2014 🏛 Wiley-VCH Verlag GmbH & Co. KGaA 🌐 German ⚖ 314 KB

Combination of the anti-CD30-auristatin-

✍ Ezogelin Oflazoglu; Kim M. Kissler; Eric L. Sievers; Iqbal S. Grewal; Hans-Peter 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 242 KB

523 POSTER Combination of the anti-CD30–

✍ H.P. Gerber; E. Oflazoglu; K. Kissler; D. Kennedy; E.L. Sievers; N.C. Ihle; D.L. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 72 KB

The use of an antibody drug conjugate, g

✍ Keir, Christopher H; Vahdat, Linda T 📂 Article 📅 2012 🏛 Informa plc 🌐 English ⚖ 246 KB

Clinical pharmacology of trastuzumab emt

✍ Sandhya Girish; Manish Gupta; Bei Wang; Dan Lu; Ian E. Krop; Charles L. Vogel; H 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 520 KB

Anti-CD22-MCC-DM1: an antibody-drug conj

✍ Polson, A G; Williams, M; Gray, A M; Fuji, R N; Poon, K A; McBride, J; Raab, H; 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 642 KB